Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06499844 · ClinicalTrials.gov registry record · Early Phase 1

Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation

A Early Phase 1 study of Endothelial Function, sponsored by University of Iowa.

Recruiting
Registry status
Early Phase 1
Development phase
56
Enrollment target
1
Study location

NCT06499844: Recruiting Early Phase 1 study of Endothelial Function, sponsored by University of Iowa.

NCT06499844 is a Early Phase 1 study of Endothelial Function that is actively recruiting participants, run by University of Iowa. The registered enrollment target is 56 participants, above the 21-participant average among 3 other Endothelial Function trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06499844, a Early Phase 1 study of Endothelial Function, is actively recruiting participants, sponsored by University of Iowa.

RECRUITING
Registry status
Early Phase 1
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these assessments. More recently, many investigators have adopted rapid local to 39°C instead, based on its larger dependency on NO and therefore improved ability to quantify NO-dependent dilation without the use of pharmacological techniques. However, to date, only one direct methodological comparison between these protocols has been performed. In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) they examine the blood vessels in a nickel-sized area of the skin in young adults ages 18 - 30 years old. Local heating of the skin at the microdialysis sites is used to explore differences in mechanisms governing microvascular control. As a compliment to these measurements, the investigators also have participants fill out a variety of surveys to assess things such as sleep quality, physical activity, daily stressors, etc.

Primary Outcome

cutaneous vascular vasodilator response to exogenous acetylcholine perfusion; measured with laser-Doppler flowmetry coupled with intradermal microdialysis delivery of acetylcholine alone or co-infused with L-NAME

Conditions Studied

Interventions

  • DRUG Acetylcholine

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2024-08-01
Est. Completion 2026-09
Phase Early Phase 1
University of Iowa

228 total trials

What NCT06499844 shows while recruiting

NCT06499844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, above the 21-participant average among 3 other Endothelial Function trials with a reported enrollment target (167% higher).

The record links to 1 condition, with Endothelial Function appearing as the primary indexed condition, and to 1 intervention - of which Acetylcholine is the first listed.

NCT06499844 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT06499844 about?

NCT06499844 is a clinical study titled "Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation". The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these a...

What is the current status of trial NCT06499844?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 56 participants. The study started on 2024-08-01. Estimated completion is 2026-09.

What conditions does trial NCT06499844 study?

This clinical trial studies the following conditions: Endothelial Function.

What interventions are being tested in trial NCT06499844?

The interventions under investigation include: Acetylcholine (DRUG).

Who is sponsoring clinical trial NCT06499844?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06499844 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endothelial Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06499844, the US trial registry maintained by the National Library of Medicine. NCT06499844 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.